When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. We’ve spent hours evaluating each of the programs below based around the extra features ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.75% to £21.30 Friday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.73 ...

The first phase is part of the newly expanded 650 MW Build-Own-Operate (BOO) Ras Ghareb wind farm in Egypt, which is developed by the Red Sea Wind Energy, a consortium comprising ENGIE with a share of ...

dapagliflozin 5 or 10 mg, and empagliflozin 10 or 25 mg. Ertugliflozin (Steglatro; Merck Sharp & Dohme), the newest of the SGLT2 inhibitors, approved in late 2017, was excluded from the analysis.

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally ...

A separate team of investigators is recruiting patients with ADPKD for a dedicated clinical trial of empagliflozin. “In ADPKD, SGLT2 inhibitors are expected to exert protective effects on the kidneys ...

Body Dimensions 171.8 x 78 x 8.9 mm (6.76 x 3.07 x 0.35 in) ...

MG showcased three new offerings, including an electric MPV, a flagship SUV and an SUV with a new powertrain option at the Auto Expo 2025 MG has gone all guns blazing at the Bharat Mobility Global ...

Thanks for sharing, man! MG Motor India has unveiled the Cyberster at the 2025 Auto Expo. While the electric sportscar was revealed back in 2024, this is the first time it has been showcased in India.

MG introduced the Majestor three-row SUV at the Bharat Mobility Expo in India. The new SUV is a basically rebadged Maxus/LDV D90. MG describes the Majestor as the “tallest, longest, and widest ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...